Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability- In silico approach
Introduction: Multidrug resistance (MDR) is primarily associated with reduced intracellular drug accumulation owing to overexpression of p-glycoprotein, an active efflux transporter. Competitive inhibition or allosteric modulation of p-glycoprotein may alter the pharmacokinetics of the drugs that se...
Saved in:
Main Authors: | Chandana Roy (Author), Pratiti Ghosh (Author) |
---|---|
Format: | Book |
Published: |
Shahrekord University of Medical Sciences,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P-glycoprotein expression in oral lichen planus
by: Abhishek Jana, et al.
Published: (2017) -
Oral etoposide and zosuquidar bioavailability in rats: Effect of co-administration and in vitro-in vivo correlation of P-glycoprotein inhibition
by: Rasmus Blaaholm Nielsen, et al.
Published: (2021) -
Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability
by: Thi-, et al.
Published: (2021) -
P-glycoprotein polymorphism and levothyroxine bioavailability in hypothyroid patients
by: Ezgi Öztaş, et al.
Published: (2018) -
Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
by: Marika Ruponen, et al.
Published: (2021)